These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 35854043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK, Yang AH, Lai HC, Lin BS.
    BMC Nephrol; 2017 May 25; 18(1):170. PubMed ID: 28545410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F, Leung N, Belmouaz M, Royal V, Ronco P, Nasr SH, Fermand JP, International Kidney and Monoclonal Gammopathy Research Group.
    Kidney Int; 2021 Mar 25; 99(3):570-580. PubMed ID: 33440212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
    Hada R, Poudyal B, Sharma A, Khatri R.
    JNMA J Nepal Med Assoc; 2012 Mar 25; 52(188):192-5. PubMed ID: 23591252
    [Abstract] [Full Text] [Related]

  • 7. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
    Yong ZH, Yu XJ, Lin ZS, Zhou FD, Cen XN, Wang SX, Zhao MH.
    BMC Nephrol; 2021 Jan 06; 22(1):6. PubMed ID: 33407225
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct 06; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 9. Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.
    Sun LJ, Dong HR, Xu XY, Wang GQ, Cheng H, Chen YP.
    BMC Nephrol; 2021 Jan 28; 22(1):42. PubMed ID: 33509125
    [Abstract] [Full Text] [Related]

  • 10. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
    Ueda H, Kuno H, Takahashi D, Katsuma A, Kimura A, Nakashima A, Kato J, Momoki M, Ohba R, Dobashi N, Yamamoto I, Kawamura T, Miyazaki Y, Yokoo T.
    CEN Case Rep; 2020 May 28; 9(2):165-172. PubMed ID: 31974826
    [Abstract] [Full Text] [Related]

  • 11. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.
    Gharwan H, Truica CI.
    Med Oncol; 2012 Jun 28; 29(2):1197-201. PubMed ID: 21479696
    [Abstract] [Full Text] [Related]

  • 12. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
    Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP, MYRE Study Group.
    JAMA; 2017 Dec 05; 318(21):2099-2110. PubMed ID: 29209721
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
    Sens F, Chaintreuil D, Jolivot A, Guebre-Egziabher F, Robinson P, Karlin L, Bridoux F, Juillard L.
    Am J Nephrol; 2017 Dec 05; 46(5):355-363. PubMed ID: 29017155
    [Abstract] [Full Text] [Related]

  • 14. A case of primary renal allograft dysfunction due to myeloma cast nephropathy.
    Lingaraj U, Vankalakunti M, Radhakrishnan H, Sreedhara CG, Rajanna S.
    Saudi J Kidney Dis Transpl; 2015 Sep 05; 26(5):970-5. PubMed ID: 26354571
    [Abstract] [Full Text] [Related]

  • 15. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.
    Bouchet A, Teuma C, Nouvier M, Rousset P, Javaugue V, Lazareth A, Lombard C, Isaac S, Fouque D.
    Am J Kidney Dis; 2019 Nov 05; 74(5):700-702. PubMed ID: 31155325
    [Abstract] [Full Text] [Related]

  • 16. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
    Lin ZS, Qin AB, Wang SX, Yu XJ, Dong B, Xiong ZY, Chen MH, Zhou FD, Zhao MH.
    J Nephrol; 2021 Aug 05; 34(4):1169-1177. PubMed ID: 33394345
    [Abstract] [Full Text] [Related]

  • 17. [Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury].
    Rekhtina IG, Kazarina EV, Stolyarevich ES, Kovrigina AM, Dvirnyk VN, Kulikov SM, Mendeleeva LP.
    Ter Arkh; 2020 Sep 01; 92(7):63-69. PubMed ID: 33346446
    [Abstract] [Full Text] [Related]

  • 18. Myeloma light chain cast nephropathy, a review.
    Sathick IJ, Drosou ME, Leung N.
    J Nephrol; 2019 Apr 01; 32(2):189-198. PubMed ID: 29730782
    [Abstract] [Full Text] [Related]

  • 19. Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.
    Steiner N, Abdel Hamid A, Kronbichler A, Neuwirt H, Myslivecek M, Kollar M, Lachmanova J, Rysava R, Hruskova Z, Spicka I, Willenbacher W, Nachbaur D, Wolf D, Tesar V, Gunsilius E.
    J Nephrol; 2021 Aug 01; 34(4):1263-1270. PubMed ID: 33382447
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.